Article thumbnail

HIV RNA suppression rates after 24 weeks of treatment with etravirine, darunavir/ritonavir and raltegravir in the etravirine early access programme

By E Florence, S De Wit, A Castagna, E Ribera, A Hill, H Vanaken, Y van Delft and S Marks
Publisher: SAGE Publications
Year: 2010
DOI identifier: 10.1258/ijsa.2009.009425
OAI identifier:
Provided by: MUCC (Crossref)
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • (external link)
  • Suggested articles

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.